| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/13/2003 | WO2003011294A2 Mucin synthesis inhibitors |
| 02/13/2003 | WO2003011291A1 Transdermal therapeutic system (reservoir-tts) for using pramipexole and ropinirole |
| 02/13/2003 | WO2003011283A1 Pharmaceutical compositions of amlodipine and atorvastatin |
| 02/13/2003 | WO2003011278A1 Crystalline composition containing escitalopram |
| 02/13/2003 | WO2003011268A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 02/13/2003 | WO2003011266A2 Azalide antibiotic compositions |
| 02/13/2003 | WO2003011261A1 Cyanoacrylate monomer-containing antibiotic formulation for topical use |
| 02/13/2003 | WO2003011260A1 Method for the continuous production and coating of self-adhesive compounds on the basis of sbc that includes at least one pharmaceutically active substance |
| 02/13/2003 | WO2003011259A1 Improved edible film formulations containing maltodextrin |
| 02/13/2003 | WO2003011258A1 Pharmaceutical formulations comprising ketoconazole |
| 02/13/2003 | WO2003011257A1 Composition and process the manufacture of soluble containers with improved gel-strength |
| 02/13/2003 | WO2003011256A1 Oral controlled release pharmaceutical composition of a prokinetic agent |
| 02/13/2003 | WO2003011255A1 Gastric retention controlled drug delivery system |
| 02/13/2003 | WO2003011254A1 Amorphous drug beads |
| 02/13/2003 | WO2003011253A1 Synergistic filler composition |
| 02/13/2003 | WO2003011252A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | WO2003011251A1 Pulmonary formulation |
| 02/13/2003 | WO2003011249A2 Ophthalmic composition containing n-acetylcysteine for the treat ment of dry-eye syndrome |
| 02/13/2003 | WO2003011248A1 Flat, oral dosage form comprising particles containing active ingredients |
| 02/13/2003 | WO2003011247A2 Support matrix comprising particles loaded with active ingredient for application on the skin or mucous membrane |
| 02/13/2003 | WO2003011245A1 Composition based on lipid lamellar vesicles incorporating at least a dhea compound |
| 02/13/2003 | WO2003011239A2 Sunscreen composition |
| 02/13/2003 | WO2003011233A1 Cosmetic raw material having improved properties and processes for preparing the same |
| 02/13/2003 | WO2003011229A2 Durable multi-component antibiotic formulation for topical use |
| 02/13/2003 | WO2003011227A2 Taste masking composition |
| 02/13/2003 | WO2003011224A2 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| 02/13/2003 | WO2003011214A2 Novel methods and formulations for administration of active agents |
| 02/13/2003 | WO2003011212A2 Biodegradable polyhydric alcohol esters |
| 02/13/2003 | WO2003011208A2 Composition based on lipid lamellar vesicles incorporating at least a dhea compound |
| 02/13/2003 | WO2003011207A2 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine |
| 02/13/2003 | WO2003011205A2 Encapsulation products for controlled or extended release |
| 02/13/2003 | WO2003011204A2 Drug delivery systems |
| 02/13/2003 | WO2003011051A1 Process for preparing concentrate thickener compositions |
| 02/13/2003 | WO2003011042A1 Soluble roasted chicory with high inulin content |
| 02/13/2003 | WO2003011008A2 Therapeutic delivery compositions and methods of use thereof |
| 02/13/2003 | WO2002097054A3 Shaped microcomponents via reactive conversion of biologically-derived microtemplates |
| 02/13/2003 | WO2002096457A3 Stable liquid formulations of antibodies |
| 02/13/2003 | WO2002094275A8 Use of estrogen compounds to increase libido in women |
| 02/13/2003 | WO2002093132A3 Method for manufacture of fine particles |
| 02/13/2003 | WO2002087546A3 Method for manufacturing a low dose pharmaceutical composition |
| 02/13/2003 | WO2002083079A3 Aerosol compositions containing formoterol for delivery to the lungs via nebulization |
| 02/13/2003 | WO2002074231A3 Cosmetic and dermopharmaceutical compositions comprising standardised extracts of hierochloe odorata |
| 02/13/2003 | WO2002072723A3 Gelatin manufacturing process and product |
| 02/13/2003 | WO2002072011A3 Stabilized therapeutic and imaging agents |
| 02/13/2003 | WO2002069232A3 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
| 02/13/2003 | WO2002067761A3 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 02/13/2003 | WO2002060454B1 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 02/13/2003 | WO2002051391A3 Process for the preparation of medicated gums |
| 02/13/2003 | WO2002051388A3 Treatment of inoperable tumors by stereotactic injection of microspheres |
| 02/13/2003 | WO2002043765A9 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
| 02/13/2003 | WO2002040056A8 Carrageenan viscoelastics for ocular surgery |
| 02/13/2003 | WO2002038129A3 Delayed-release pharmaceutical formulations containing proinsulin c-peptide |
| 02/13/2003 | WO2002028382A9 Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals |
| 02/13/2003 | WO2002028366A9 Devices and methods for management of inflammation |
| 02/13/2003 | WO2002013791A3 Steroid hormones as transfer agents |
| 02/13/2003 | US20030032995 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 02/13/2003 | US20030032964 Vertebroplasty bone cement |
| 02/13/2003 | US20030032947 Osmotic pump drug delivery systems and methods |
| 02/13/2003 | US20030032946 Artificial synapse chip interface for electronic prosthetic retina |
| 02/13/2003 | US20030032945 Coated filter bag material for oral administration of medicament in liquid and methods of making same |
| 02/13/2003 | US20030032943 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 02/13/2003 | US20030032917 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 02/13/2003 | US20030032909 Plaster containing an active agent |
| 02/13/2003 | US20030032770 Extraction of glycoprotein from a polar solution; obtain a polar solvent, mix with nonpolar solvent, form glycoprotein interface layer, recover glycoprotein, replace solution |
| 02/13/2003 | US20030032675 Apparatus for transporting thyroid hormone drug formulations from a blender to a tableting machine; especially for treatment of hypothyroidism in cats and dogs |
| 02/13/2003 | US20030032662 Micronized leflunomide |
| 02/13/2003 | US20030032659 Stabilization of retinoid compounds |
| 02/13/2003 | US20030032640 Novel composition |
| 02/13/2003 | US20030032638 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of a benzodiazepine such as clonazepam, flunitrazepam or flurazepam. |
| 02/13/2003 | US20030032632 Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
| 02/13/2003 | US20030032628 Wet granulation formulation for bisphosphonic acids |
| 02/13/2003 | US20030032619 Pharmaceutical composition |
| 02/13/2003 | US20030032616 Increasing cerebral bioavailability of drugs |
| 02/13/2003 | US20030032615 Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response |
| 02/13/2003 | US20030032610 Administering one or more oligonucleotides which share at least 50% nucleotide sequence identity with (TTAGGG)n or oligonucleotides which share at least 50% nucleotide sequence identity with the human telomere overhang repeat. |
| 02/13/2003 | US20030032601 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof |
| 02/13/2003 | US20030032600 Taste masked liquid pharmaceutical compositions |
| 02/13/2003 | US20030032598 Method to treat pulmonary hypoplasia in the newborn |
| 02/13/2003 | US20030031784 Comprises coating agent particles dispersed in fluid at supercritical pressure; solvent extraction; precipitation to form microcapsules |
| 02/13/2003 | US20030031739 Dietary supplement of an aqueous extract of red vine leaves and carrier; relief of mild-to-moderate leg discomfort; flavonoids; antiinflammatory, -oxidant, -coagulant and -edema properties; hyaluronidase inhibitors |
| 02/13/2003 | US20030031737 Medicinal composition and method of using it |
| 02/13/2003 | US20030031733 Pharmaceutical composition for increasing the production of nitric oxide and IFN-gamma, and process for preparation thereof |
| 02/13/2003 | US20030031723 Active substance, e.g. a solution of plant extract, absorbed and/or adsorbed on a dry slightly substituted cellulosic hydroxypropylated polymer obtained using an extrusion and spheronizing method; allows dry form to be administered |
| 02/13/2003 | US20030031721 Micro- and nano-particulate drugs and methods of making thereof |
| 02/13/2003 | US20030031720 Granulating the drug such as cerivastatin with spray-dried D-mannitol and, optionally other binders and/or excipients and drying the resulting granules |
| 02/13/2003 | US20030031719 Method for preparing submicron particle suspensions |
| 02/13/2003 | US20030031718 Once-a-day, topical mixture of ketotifen, a chitosan, and a carrier to administer to the eye to treat allergies |
| 02/13/2003 | US20030031717 Durable multi-component antibiotic formulation for topical use |
| 02/13/2003 | US20030031716 Biocompatible polymer and particles of metal cation-stabilized interferon dispersed within the polymer |
| 02/13/2003 | US20030031715 Increasing the water solubility of poorly soluble drugs such as paclitaxel, griseofulvin, progesterone, or tamoxifen using hydrotropic agent monomers, polymers, or hydrogels, which contain at least one hydrophobic moiety |
| 02/13/2003 | US20030031714 Impermeable reservoir with water-swellable agent chamber and drug chamber, fluid is imbibed through a semipermeable plug into the water-swellable agent chamber and the drug is released through back diffusion; treating prostate cancer |
| 02/13/2003 | US20030031713 Extended release oral dosage composition |
| 02/13/2003 | US20030031712 Opioid agonist /antagonist combinations |
| 02/13/2003 | US20030031711 Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough |
| 02/13/2003 | US20030031710 Process and composition for temporarily suppressing pain |
| 02/13/2003 | US20030031709 For sublingual administration of peptides, a mostly anhydrous medium, a non-volatile water soluble solvent, and a topical vasodilator; liquids and tablets |
| 02/13/2003 | US20030031708 Comprising vinylpyrrolidone-vinyl acetate copolymer and microcrystalline cellulose; for making pharmaceutical tablets of sufficient tablet hardness at low compression force and low friability to preclude damage on processing |
| 02/13/2003 | US20030031707 Use of a multilayer tablet comprising layer(s) of sustained release carbidopa-levodopa adjacent to layer(s) of immediate release of carbidopa-levodopa; dosage forms; oral drug delivery system |
| 02/13/2003 | US20030031706 Carotenoid formulations, comprising a mixture of beta-carotene, lycopene and lutein |
| 02/13/2003 | US20030031705 Solid dispersion of a disintegrant in fenofibrate; bioavailability; made by melting the fenofibrate, blending the disintegrant into the melt, and resolidifying the mixture |